↓ Skip to main content

Cochrane Database of Systematic Reviews

Nicergoline for dementia and other age associated forms of cognitive impairment

Overview of attention for article published in Cochrane database of systematic reviews, October 2001
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)

Mentioned by

twitter
3 tweeters
wikipedia
6 Wikipedia pages

Citations

dimensions_citation
68 Dimensions

Readers on

mendeley
160 Mendeley
Title
Nicergoline for dementia and other age associated forms of cognitive impairment
Published in
Cochrane database of systematic reviews, October 2001
DOI 10.1002/14651858.cd003159
Pubmed ID
Authors

Mario Fioravanti, Leon Flicker

Abstract

Nicergoline is an ergot derivative currently in use in over fifty countries for more than three decades, for the treatment of cognitive, affective, and behavioral disorders of older people. It was initially considered as a vasoactive drug and mainly prescribed for cerebrovascular disorders. Recent findings suggest other actions which has provided a rationale for the use of nicergoline for the treatment of various forms of dementia, including Alzheimer's Disease.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 160 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Germany 1 <1%
Unknown 158 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 23 14%
Student > Master 20 13%
Student > Bachelor 19 12%
Researcher 16 10%
Other 8 5%
Other 33 21%
Unknown 41 26%
Readers by discipline Count As %
Medicine and Dentistry 41 26%
Psychology 20 13%
Agricultural and Biological Sciences 9 6%
Social Sciences 7 4%
Neuroscience 6 4%
Other 30 19%
Unknown 47 29%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 December 2019.
All research outputs
#5,824,094
of 21,326,395 outputs
Outputs from Cochrane database of systematic reviews
#7,801
of 12,040 outputs
Outputs of similar age
#55,184
of 215,095 outputs
Outputs of similar age from Cochrane database of systematic reviews
#160
of 217 outputs
Altmetric has tracked 21,326,395 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 12,040 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.0. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 215,095 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 217 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.